266 related articles for article (PubMed ID: 27072025)
1. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs.
Stremersch S; Vandenbroucke RE; Van Wonterghem E; Hendrix A; De Smedt SC; Raemdonck K
J Control Release; 2016 Jun; 232():51-61. PubMed ID: 27072025
[TBL] [Abstract][Full Text] [Related]
2. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
[TBL] [Abstract][Full Text] [Related]
3. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.
O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P
Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161
[TBL] [Abstract][Full Text] [Related]
4. SELEX-Based Screening of Exosome-Tropic RNA.
Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
[TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Small Interfering RNAs to Cells via Exosomes.
Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
[TBL] [Abstract][Full Text] [Related]
8. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
9. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
10. Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice.
Jalabert A; Vial G; Guay C; Wiklander OP; Nordin JZ; Aswad H; Forterre A; Meugnier E; Pesenti S; Regazzi R; Danty-Berger E; Ducreux S; Vidal H; El-Andaloussi S; Rieusset J; Rome S
Diabetologia; 2016 May; 59(5):1049-58. PubMed ID: 26852333
[TBL] [Abstract][Full Text] [Related]
11. Exosomes: Natural Carriers for siRNA Delivery.
Kumar L; Verma S; Vaidya B; Gupta V
Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated small RNA delivery for gene therapy.
Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
[TBL] [Abstract][Full Text] [Related]
13. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and Preclinical Evaluation of Spermine-Derived Surfactant Liposomes for in Vitro and in Vivo siRNA-Delivery to Liver Macrophages.
Müller LK; Kaps L; Schuppan D; Brose A; Chai W; Fischer K; Müller S; Frey H; Schmidt M; Mohr K
Mol Pharm; 2016 Nov; 13(11):3636-3647. PubMed ID: 27700112
[TBL] [Abstract][Full Text] [Related]
15. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
17. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.
Yang Z; Xie J; Zhu J; Kang C; Chiang C; Wang X; Wang X; Kuang T; Chen F; Chen Z; Zhang A; Yu B; Lee RJ; Teng L; Lee LJ
J Control Release; 2016 Dec; 243():160-171. PubMed ID: 27742443
[TBL] [Abstract][Full Text] [Related]
18. Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells.
Cui ZK; Fan J; Kim S; Bezouglaia O; Fartash A; Wu BM; Aghaloo T; Lee M
J Control Release; 2015 Nov; 217():42-52. PubMed ID: 26302903
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of exosome-like vesicles derived from breast cancer cells.
Palazzolo G; Albanese NN; DI Cara G; Gygax D; Vittorelli ML; Pucci-Minafra I
Anticancer Res; 2012 Mar; 32(3):847-60. PubMed ID: 22399603
[TBL] [Abstract][Full Text] [Related]
20. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
